Professor Dr. Engin Ulukaya, after graduating from Istanbul University Cerrahpaşa Medical Faculty in 1987, completed his Medical Biochemistry specialization at Uludağ University. He completed his doctorate (PhD) at the University of Leeds (UK), School of Biochemistry and Molecular Biology. He is working on basic cancer research, cell death, cancer drug development, and personal oncology. In addition to being the chair of the Molecular Cancer Research Association (MOKAD), he is a member of the Council in EACR (European Association for Cancer Research) and a full member of the EORTC PathoBiology...
Professor Dr. Engin Ulukaya, after graduating from Istanbul University Cerrahpaşa Medical Faculty in 1987, completed his Medical Biochemistry specialization at Uludağ University. He completed his doctorate (PhD) at the University of Leeds (UK), School of Biochemistry and Molecular Biology. He is working on basic cancer research, cell death, cancer drug development, and personal oncology. In addition to being the chair of the Molecular Cancer Research Association (MOKAD), he is a member of the Council in EACR (European Association for Cancer Research) and a full member of the EORTC PathoBiology subgroup. He has published about 200 articles in international journals (Google scholar H index: 48, number of citations: 7020, April 2025). He received the “promising laboratory physician” award at the world pathology and laboratory medicine association (WASPALM) congress held in South Korea in 2003 and was awarded the WASPALM medal. He also has 32 awards in various categories, 3 of which are abroad. He is the Dean of Health Sciences at Istinye University. He is also the Director of the Molecular Cancer Application and Research Center (ISUMKAM) of the same university.